This article was originally published in The Rose Sheet
The “Chemical Safety Improvement Act of 2013” would reform chemicals regulation in the U.S. by requiring manufacturers to submit safety data and prioritizing high-risk substances for further evaluation by the Environmental Protection Agency. More news in brief.
You may also be interested in...
Coty Projects Slight Q1 Decline, Citing “Drastic Drop” In Nail Segment
Coty is holding off on full-year projections until it gains visibility into the back-to-school and Christmas seasons, but expects first-quarter revenues to be down, largely due to a significant decline in nail-care consumption. The newly public firm looks to offset retailer destocking with innovations across its portfolio, previewed during its fiscal 2013 fourth-quarter and year-end earnings call.
Chemical Safety Improvement Act Promises Stronger EPA Oversight
Introduced by New Jersey Sen. Frank Lautenberg, the Chemical Safety Improvement Act of 2013 would give EPA authority to evaluate chemicals in commerce based on risk to human health and the environment and take action on those deemed unsafe. The bill would update the current Toxic Substances Control Act and potentially impact manufacturers of cosmetic ingredients.
FDA issued warning letters Sept. 21 to two skin-care companies it says are making unapproved drug claims. More news in brief.